GT Biosciences is developing a platform to design and optimize
cell and tissue-specific delivery solutions for genomic medicines.
mRNA and gene editors hold great promise as modular therapeutics but face challenges in achieving safe and effective delivery to the target cells and tissues in the body.
We are generating proprietary and unique data to measure the performance of hundreds of delivery vehicles precisely across diverse cell and tissue types.
Powered by state-of-the-art AI, we are screening billions of delivery vehicles to achieve effective, cell-specific delivery in vivo.
We are a team of MIT PhDs on a mission to transform the future of genomic medicines.
Reach out at hello@gtbiosciences.com if you want to make an impact together!